Attached files
file | filename |
---|---|
8-K - FORM 8-K - SELECT MEDICAL HOLDINGS CORP | c24227e8vk.htm |
Exhibit 99.1
FOR IMMEDIATE RELEASE | 4714 Gettysburg Road Mechanicsburg, PA 17055 NYSE Symbol: SEM |
Select Medical Holdings Corporation Announces
Results for Third Quarter Ended September 30, 2011
Results for Third Quarter Ended September 30, 2011
MECHANICSBURG, PENNSYLVANIA November 3, 2011 Select Medical Holdings Corporation
(Select Medical) (NYSE: SEM), today announced results for its third quarter ended September 30,
2011.
For the third quarter ended September 30, 2011, net operating revenues increased 18.0% to
$694.1 million compared to $588.3 million for the same quarter, prior year. Income from operations
increased 62.3% to $68.1 million compared to $42.0 million for the same quarter, prior year. Net
income attributable to Select Medical increased to $25.6 million compared to $8.0 million for the
same quarter, prior year. Net income before interest, income taxes, depreciation and amortization,
stock compensation expense, other income, loss on early retirement of debt and equity in earnings
(losses) of unconsolidated subsidiaries (Adjusted EBITDA) for the third quarter increased 45.6%
to $86.5 million compared to $59.4 million for the same quarter, prior year. A reconciliation of
net income to Adjusted EBITDA is contained in table VII of this release. Income per common share
for the third quarter ended September 30, 2011 was $0.17 on a fully diluted basis compared to
income per common share of $0.05 for the quarter ended September 30, 2010.
For the nine months ended September 30, 2011, net operating revenues increased 19.0% to
$2,086.1 million compared to $1,752.9 million for the same period, prior year. Income from
operations increased 26.5% to $236.7 million compared to $187.2 million for the same period, prior
year. Net income attributable to Select Medical increased 25.2% to $71.0 million compared to $56.7
million for the same period, prior year. Net income attributable to Select Medical for the nine
months ended September 30, 2011 includes a loss on early retirement of debt, net of tax, of $19.2
million associated with the June 1, 2011 refinancing of a portion of its indebtedness.
Additionally, Adjusted EBITDA for the nine months ended September 30, 2011 increased 21.8% to
$292.2 million compared to $239.9 million for the same period, prior year. A reconciliation of net
income to Adjusted EBITDA is contained in table VII of this release. Income per common share for
the nine months ended September 30, 2011 was $0.46 on a fully diluted basis compared to income per
common share of $0.35 for the nine months ended September 30, 2010. Excluding the loss related to
the early retirement of debt and its tax effect, net income available to common stockholders on an
adjusted basis (Adjusted Net Income Per Share) was $0.59 per diluted share for the nine months
ended September 30, 2011. A reconciliation of net income per share to Adjusted Net Income Per
Share is contained in table VIII of this release.
Specialty Hospitals
Certain specialty hospital key statistics are contained on tables V and VI of this release.
For the third quarter of 2011, net operating revenues for all of Select Medicals hospitals
increased 24.1% to $521.1 million compared to $419.8 million for the same quarter, prior year. The
hospitals acquired in the Regency acquisition on September 1, 2010 contributed $84.1 million of net
operating revenue, or $61.3 million of this increase. Adjusted EBITDA for the specialty hospital
segment increased 40.0% to $81.6 million compared to $58.3 million for the same quarter, prior
year. The hospitals acquired in the Regency acquisition contributed $12.7 million of this
increase. The Adjusted EBITDA margin for the segment was 15.7% for the third quarter of 2011,
compared to 13.9% for the same quarter, prior year. Excluding the effect of the Regency hospitals,
the Adjusted EBITDA margin would have been 16.0% for the third quarter of 2011, compared to 14.9%
for the same quarter, prior year.
For the nine months ended September 30, 2011, net operating revenues for all of Select
Medicals hospitals increased 26.5% to $1,561.3 million compared to $1,234.6 million for the same
period, prior year. The hospitals acquired in the Regency acquisition contributed $255.0 million
of net operating revenue, or $232.2 million of this increase. Adjusted EBITDA for the segment for
the nine months ended September 30, 2011 increased 27.3% to $273.0 million compared to $214.5
million for the same period, prior year. The hospitals acquired in the Regency acquisition
contributed $35.9 million of this increase. The Adjusted EBITDA margin for the segment for the
nine months ended September 30, 2011 was 17.5%, compared to 17.4% for the same period, prior year.
Excluding the effect of the Regency hospitals, the Adjusted EBITDA margin would have been 18.2% for
the nine months ended September 30, 2011, compared to 17.8% for the same period, prior year.
Outpatient Rehabilitation
Certain outpatient rehabilitation key statistics are contained in tables V and VI of this
release. For the third quarter of 2011, net operating revenues for the outpatient rehabilitation
segment increased 2.7% to $173.0 million compared to $168.4 million for the same quarter, prior
year. Adjusted EBITDA for the segment for the third quarter decreased 4.4% to $19.4 million
compared to $20.3 million for the same quarter, prior year. The Adjusted EBITDA margin for the
segment was 11.2% for the third quarter of 2011, compared to 12.1% for the same quarter, prior
year.
For the nine months ended September 30, 2011, net operating revenues for the outpatient
rehabilitation segment increased 1.2% to $524.7 million compared to $518.3 million for the same
period, prior year. Adjusted EBITDA for the nine months ended September 30, 2011 decreased 2.3% to
$65.3 million compared to $66.8 million for the same period, prior year. The Adjusted EBITDA
margin for the nine months ended September 30, 2011 was 12.4% compared to 12.9% in the same period,
prior year.
Stock Repurchase Program
On August 3, 2011, the board of directors of Select Medical authorized an increase of $50.0
million in the capacity of its common stock repurchase program from $100.0 million to $150.0
million. The program will now remain in effect until March 31, 2013, unless extended by the board
of directors. Stock repurchases under this program may be made in the open market or through
privately negotiated transactions, and at times and in such amounts as Select Medical deems
appropriate. The timing of purchases of stock will be based upon market conditions and other
factors. Select Medical is funding this program with cash on hand or borrowings under its
revolving credit facility. Select Medical repurchased 4,239,972 shares at a cost of $28.4 million
and 4,649,747 shares at a cost of $31.6 million, which includes transaction costs, during the
quarter and nine months ended September 30, 2011, respectively. Since the inception of the program
through September 30, 2011, Select Medical has repurchased 11,555,447 shares at a cost of $75.8
million, which includes transaction costs.
Business Outlook
Select Medical is increasing its prior business outlook for calendar year 2011. Select Medical
now expects net revenue for the full year 2011 to be in the range of $2.76 billion to $2.80 billion
and Adjusted EBITDA for the full year to be in the range of $375 million to $390 million. Select
Medical expects fully diluted income per common share to be in the range of $0.62 to $0.68.
Adjusted Net Income Per Share is now expected to be in the range of $0.75 to $0.81.
Conference Call
Select Medical will host a conference call regarding its third quarter results and its
business outlook on Friday, November 4, 2011, at 9:00 am EDT. The domestic dial in number for the
call is
1-800-706-7745. The international dial in number is 1-617-614-3472. The pass code for the
call is 57051359. The conference call will be webcast simultaneously and can be accessed at Select
Medical Holdings Corporations website
http://www.selectmedicalholdings.com/.
For those unable to participate in the conference call, a replay will be available until
11:59pm EST, November 11, 2011. The replay number is 1-888-286-8010 (domestic) or 1-617-801-6888
(international). The passcode for the replay will be 42934406. The replay can also be accessed at
Select Medical Holdings Corporations website,
http://www.selectmedicalholdings.com.
* * * * *
Select Medical is a leading operator of specialty hospitals and outpatient rehabilitation
clinics in the United States. As of September 30, 2011, Select Medical operated 110 long term
acute care hospitals and nine acute medical rehabilitation hospitals in 28 states, and 952
outpatient rehabilitation clinics in 34 states and the District of Columbia. Select Medical also
provides medical rehabilitation services on a contract basis at nursing homes, hospitals, assisted
living and senior care centers, schools and worksites. Information about Select Medical is
available at http://www.selectmedical.com/
Certain statements contained herein that are not descriptions of historical facts are
forward-looking statements (as such term is defined in the Private Securities Litigation Reform
Act of 1995). Because such statements include risks and uncertainties, actual results may differ
materially from those expressed or implied by such forward-looking statements due to factors
including the following:
| additional changes in government reimbursement for our services, including changes that
will result from the expiration of the moratorium for long term acute care hospitals
established by the Medicare, Medicaid and SCHIP Extension Act of 2007, the American
Recovery and Reinvestment Act, and the Patient Protection and Affordable Care Act may
result in a reduction in net operating revenues, an increase in costs and a reduction in
profitability; |
| the failure of our specialty hospitals to maintain their Medicare certifications may
cause our net operating revenues and profitability to decline; |
| the failure of our facilities operated as hospitals within hospitals to qualify as
hospitals separate from their host hospitals may cause our net operating revenues and
profitability to decline; |
| a government investigation or assertion that we have violated applicable regulations
may result in sanctions or reputational harm and increased costs; |
| acquisitions or joint ventures may prove difficult or unsuccessful, use significant
resources or expose us to unforeseen liabilities; |
| private third-party payors for our services may undertake future cost containment
initiatives that limit our future net operating revenues and profitability; |
| the failure to maintain established relationships with the physicians in the areas we
serve could reduce our net operating revenues and profitability; |
| shortages in qualified nurses or therapists could increase our operating costs
significantly; |
| competition may limit our ability to grow and result in a decrease in our net operating
revenues and profitability; |
| the loss of key members of our management team could significantly disrupt our
operations; |
| the effect of claims asserted against us could subject us to substantial uninsured
liabilities and in the future we may not be able to obtain insurance at a reasonable price; |
| other factors discussed from time to time in our filings with the Securities and
Exchange Commission, including factors under the heading Risk Factors in our annual
report on Form 10-K. |
Investor inquiries:
Joel Veit, 717/972-1100
I. Condensed Consolidated Statements of Operations
For the Three Months Ended September 30, 2010 and 2011
(In thousands, except per share amounts, unaudited)
For the Three Months Ended September 30, 2010 and 2011
(In thousands, except per share amounts, unaudited)
2010 | 2011 | %Change | ||||||||||
Net operating revenues |
$ | 588,250 | $ | 694,131 | 18.0 | % | ||||||
Costs and expenses: |
||||||||||||
Cost of services |
498,739 | 581,829 | 16.7 | % | ||||||||
General and administrative |
19,228 | 14,975 | (22.1 | )% | ||||||||
Bad debt expense |
11,317 | 11,709 | 3.5 | % | ||||||||
Depreciation and amortization |
17,012 | 17,545 | 3.1 | % | ||||||||
Income from operations |
41,954 | 68,073 | 62.3 | % | ||||||||
Equity in earnings (losses) of unconsolidated subsidiaries |
(186 | ) | 1,653 | N/M | ||||||||
Other income |
148 | | N/M | |||||||||
Interest income |
| 119 | N/M | |||||||||
Interest expense |
(27,677 | ) | (24,134 | ) | (12.8 | )% | ||||||
Income before income taxes |
14,239 | 45,711 | 221.0 | % | ||||||||
Income tax expense |
5,574 | 19,330 | 246.8 | % | ||||||||
Net income |
8,665 | 26,381 | 204.5 | % | ||||||||
Less: Net income attributable to non-controlling interests |
656 | 785 | 19.7 | % | ||||||||
Net income attributable to Select Medical
Holdings Corporation |
$ | 8,009 | $ | 25,596 | 219.6 | % | ||||||
Income per common share: |
||||||||||||
Basic |
$ | 0.05 | $ | 0.17 | ||||||||
Diluted |
$ | 0.05 | $ | 0.17 | ||||||||
Weighted average shares outstanding: |
||||||||||||
Basic |
159,717 | 151,470 | ||||||||||
Diluted |
159,955 | 151,676 |
N/M = Not Meaningful
II. Condensed Consolidated Statements of Operations
For the Nine Months Ended September 30, 2010 and 2011
(In thousands, except per share amounts, unaudited)
For the Nine Months Ended September 30, 2010 and 2011
(In thousands, except per share amounts, unaudited)
2010 | 2011 | %Change | ||||||||||
Net operating revenues |
$ | 1,752,940 | $ | 2,086,066 | 19.0 | % | ||||||
Costs and expenses: |
||||||||||||
Cost of services |
1,441,160 | 1,708,911 | 18.6 | % | ||||||||
General and administrative |
41,819 | 47,656 | 14.0 | % | ||||||||
Bad debt expense |
31,449 | 40,002 | 27.2 | % | ||||||||
Depreciation and amortization |
51,333 | 52,766 | 2.8 | % | ||||||||
Income from operations |
187,179 | 236,731 | 26.5 | % | ||||||||
Loss on early retirement of debt |
| (31,018 | ) | N/M | ||||||||
Equity in earnings (losses) of unconsolidated subsidiaries |
(186 | ) | 1,329 | N/M | ||||||||
Other income |
464 | | N/M | |||||||||
Interest income |
| 286 | N/M | |||||||||
Interest expense |
(86,998 | ) | (75,094 | ) | (13.7 | )% | ||||||
Income before income taxes |
100,459 | 132,234 | 31.6 | % | ||||||||
Income tax expense |
39,989 | 56,809 | 42.1 | % | ||||||||
Net income |
60,470 | 75,425 | 24.7 | % | ||||||||
Less: Net income attributable to non-
controlling interests |
3,773 | 4,438 | 17.6 | % | ||||||||
Net income attributable to Select Medical
Holdings Corporation |
$ | 56,697 | $ | 70,987 | 25.2 | % | ||||||
Income per common share: |
||||||||||||
Basic |
$ | 0.35 | $ | 0.46 | ||||||||
Diluted |
$ | 0.35 | $ | 0.46 | ||||||||
Weighted average shares outstanding: |
||||||||||||
Basic |
159,698 | 152,299 | ||||||||||
Diluted |
159,964 | 152,522 |
N/M = Not Meaningful
III. Condensed Consolidated Balance Sheets
(In thousands, unaudited)
(In thousands, unaudited)
December 31, | September 30, | |||||||
2010 | 2011 | |||||||
Assets |
||||||||
Cash |
$ | 4,365 | $ | 10,213 | ||||
Accounts receivable, net |
353,432 | 394,989 | ||||||
Current deferred tax asset |
30,654 | 19,834 | ||||||
Prepaid income taxes |
12,699 | 10,340 | ||||||
Other current assets |
28,176 | 28,106 | ||||||
Total Current Assets |
429,326 | 463,482 | ||||||
Property and equipment, net |
532,100 | 505,894 | ||||||
Goodwill |
1,631,252 | 1,627,509 | ||||||
Other identifiable intangibles |
80,119 | 72,448 | ||||||
Assets held for sale |
11,342 | 11,342 | ||||||
Other assets |
37,947 | 70,435 | ||||||
Total Assets |
$ | 2,722,086 | $ | 2,751,110 | ||||
Liabilities and equity |
||||||||
Payables and accruals |
$ | 350,179 | $ | 343,220 | ||||
Current portion of long-term debt |
149,379 | 10,268 | ||||||
Total Current Liabilities |
499,558 | 353,488 | ||||||
Long-term debt, net of current portion |
1,281,390 | 1,397,418 | ||||||
Non-current deferred tax liability |
59,074 | 68,399 | ||||||
Other non-current liabilities |
66,650 | 73,219 | ||||||
Total equity |
815,414 | 858,586 | ||||||
Total Liabilities and Equity |
$ | 2,722,086 | $ | 2,751,110 | ||||
IV. Condensed Consolidated Statement of Cash Flows
For the Nine Months Ended September 30, 2010 and 2011
(In thousands, unaudited)
For the Nine Months Ended September 30, 2010 and 2011
(In thousands, unaudited)
2010 | 2011 | |||||||
Operating Activities |
||||||||
Net Income |
$ | 60,470 | $ | 75,425 | ||||
Adjustments to reconcile net income to net cash provided by operating
activities: |
||||||||
Depreciation and amortization |
51,333 | 52,766 | ||||||
Provision for bad debts |
31,449 | 40,002 | ||||||
Loss on early retirement of debt |
| 31,018 | ||||||
Loss (gain) from disposal of assets |
612 | (5,182 | ) | |||||
Non-cash gain from interest rate swaps |
(464 | ) | | |||||
Non-cash stock compensation expense |
1,405 | 2,698 | ||||||
Amortization of debt discount |
1,396 | 1,271 | ||||||
Changes in operating assets and liabilities, net of effects from
acquisition of businesses: |
||||||||
Accounts receivable |
(26,668 | ) | (81,466 | ) | ||||
Other current assets |
3,571 | 240 | ||||||
Other assets |
494 | 1,072 | ||||||
Accounts payable |
(3,469 | ) | 14,008 | |||||
Due to third-party payors |
(756 | ) | (1,050 | ) | ||||
Accrued expenses, income and deferred taxes |
(9,108 | ) | 13,112 | |||||
Net cash provided by operating activities |
110,265 | 143,914 | ||||||
Investing activities |
||||||||
Purchases of property and equipment |
(38,626 | ) | (32,094 | ) | ||||
Investment in business |
| (13,514 | ) | |||||
Acquisition of businesses, net of cash acquired |
(165,802 | ) | 1,921 | |||||
Proceeds from sale of assets |
| 7,879 | ||||||
Net cash used in investing activities |
(204,428 | ) | (35,808 | ) | ||||
Financing activities |
||||||||
Borrowings on revolving credit facilities |
90,000 | 595,000 | ||||||
Payments on revolving credit facilities |
(70,000 | ) | (570,000 | ) | ||||
Borrowings on 2011 credit facility term loan, net of discount |
| 841,500 | ||||||
Payments on 2011 credit facility term loans |
| (2,125 | ) | |||||
Payments on 2005 credit facility term loans, net of call premium |
| (484,633 | ) | |||||
Repurchase of 10% senior subordinated notes |
| (150,000 | ) | |||||
Repurchase of 7 5/8% senior subordinated notes, net of tender premium |
| (273,941 | ) | |||||
Borrowings of other debt |
5,015 | 5,496 | ||||||
Principal payments on seller and other debt |
(6,667 | ) | (5,846 | ) | ||||
Debt issuance costs |
| (18,556 | ) | |||||
Proceeds from (repayment of) bank overdrafts |
10,971 | (4,174 | ) | |||||
Repurchase of common stock |
| (31,641 | ) | |||||
Proceeds from issuance of common stock |
125 | 169 | ||||||
Distributions to non-controlling interests |
(3,618 | ) | (3,507 | ) | ||||
Net cash provided by (used in) financing activities |
25,826 | (102,258 | ) | |||||
Net increase (decrease) in cash and cash equivalents |
(68,337 | ) | 5,848 | |||||
Cash and cash equivalents at beginning of period |
83,680 | 4,365 | ||||||
Cash and cash equivalents at end of period |
$ | 15,343 | $ | 10,213 | ||||
Supplemental Cash Flow Information |
||||||||
Cash paid for interest |
$ | 99,897 | $ | 94,632 | ||||
Cash paid for taxes |
$ | 36,424 | $ | 31,105 |
V. Key Statistics
For the Three Months Ended September 30, 2010 and 2011
(unaudited)
For the Three Months Ended September 30, 2010 and 2011
(unaudited)
2010 | 2011 | %Change | ||||||||||
Specialty Hospitals |
||||||||||||
Number of hospitals end of period: |
||||||||||||
Long term acute care hospitals |
111 | 110 | ||||||||||
Rehabilitation hospitals |
6 | 9 | ||||||||||
Total specialty hospitals |
117 | 119 | ||||||||||
Net operating revenues (,000) |
$ | 419,798 | $ | 521,085 | 24.1 | % | ||||||
Number of patient days |
275,387 | 333,322 | 21.0 | % | ||||||||
Number of admissions |
11,305 | 13,599 | 20.3 | % | ||||||||
Net revenue per patient day (a) |
$ | 1,478 | $ | 1,474 | (0.3 | )% | ||||||
Adjusted EBITDA (,000) |
$ | 58,282 | $ | 81,570 | 40.0 | % | ||||||
Adjusted EBITDA margin |
13.9 | % | 15.7 | % | ||||||||
Outpatient Rehabilitation |
||||||||||||
Number of clinics end of period |
950 | 952 | ||||||||||
Net operating revenues (,000) |
$ | 168,438 | $ | 173,030 | 2.7 | % | ||||||
Number of visits |
1,144,096 | 1,099,342 | (3.9 | )% | ||||||||
Revenue per visit (b) |
$ | 101 | $ | 103 | 2.0 | % | ||||||
Adjusted EBITDA (,000) |
$ | 20,339 | $ | 19,435 | (4.4 | )% | ||||||
Adjusted EBITDA margin |
12.1 | % | 11.2 | % |
(a) | Net revenue per patient day is calculated by dividing specialty hospital direct patient service revenue by the total number of patient days. |
|
(b) | Net revenue per visit is calculated by dividing outpatient rehabilitation clinic revenue by the total number of visits. For purposes of this
computation, outpatient rehabilitation clinic revenue does not include managed clinics or contract services revenue. |
VI. Key Statistics
For the Nine Months Ended September 30, 2010 and 2011
(unaudited)
For the Nine Months Ended September 30, 2010 and 2011
(unaudited)
2010 | 2011 | %Change | ||||||||||
Specialty Hospitals |
||||||||||||
Number of hospitals end of period: |
||||||||||||
Long term acute care hospitals |
111 | 110 | ||||||||||
Rehabilitation hospitals |
6 | 9 | ||||||||||
Total specialty hospitals |
117 | 119 | ||||||||||
Net operating revenues (,000) |
$ | 1,234,562 | $ | 1,561,270 | 26.5 | % | ||||||
Number of patient days |
808,133 | 994,179 | 23.0 | % | ||||||||
Number of admissions |
33,022 | 40,965 | 24.1 | % | ||||||||
Net revenue per patient day (a) |
$ | 1,481 | $ | 1,498 | 1.1 | % | ||||||
Adjusted EBITDA (,000) |
$ | 214,523 | $ | 273,004 | 27.3 | % | ||||||
Adjusted EBITDA margin |
17.4 | % | 17.5 | % | ||||||||
Outpatient Rehabilitation |
||||||||||||
Number of clinics end of period |
950 | 952 | ||||||||||
Net operating revenues (,000) |
$ | 518,288 | $ | 524,694 | 1.2 | % | ||||||
Number of visits |
3,442,266 | 3,381,896 | (1.8 | )% | ||||||||
Revenue per visit (b) |
$ | 101 | $ | 103 | 2.0 | % | ||||||
Adjusted EBITDA (,000) |
$ | 66,813 | $ | 65,308 | (2.3 | )% | ||||||
Adjusted EBITDA margin |
12.9 | % | 12.4 | % |
(a) | Net revenue per patient day is calculated by dividing specialty hospital direct patient
service revenue by the total number of patient days. |
|
(b) | Net revenue per visit is calculated by dividing outpatient rehabilitation clinic revenue by
the total number of visits. For purposes of this computation, outpatient rehabilitation clinic
revenue does not include managed clinics or contract services revenue. |
VII. Net Income to Adjusted EBITDA Reconciliation
For the Three and Nine Months Ended September 30, 2010 and 2011
(In thousands, unaudited)
For the Three and Nine Months Ended September 30, 2010 and 2011
(In thousands, unaudited)
The following table reconciles net income to Adjusted EBITDA for Select Medical. Adjusted
EBITDA is used by Select Medical to report its segment performance. Adjusted EBITDA is defined as
net income before interest, income taxes, depreciation and amortization, stock compensation
expense, other income, loss on early retirement of debt and equity in earnings (losses) of
unconsolidated subsidiaries. The Company believes that the presentation of Adjusted EBITDA is
important to investors because Adjusted EBITDA is used by management to evaluate financial
performance and determine resource allocation for each of its operating units.
Adjusted EBITDA is not a measure of financial performance under generally accepted accounting
principles. Items excluded from Adjusted EBITDA are significant components in understanding and
assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an
alternative to, or substitute for, net income, cash flows generated by operations, investing or
financing activities, or other financial statement data presented in the consolidated financial
statements as indicators of financial performance or liquidity. Because Adjusted EBITDA is not a
measurement determined in accordance with generally accepted accounting principles and is thus
susceptible to varying calculation, Adjusted EBITDA as presented may not be comparable to other
similarly titled measures of other companies.
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2010 | 2011 | 2010 | 2011 | |||||||||||||
Net income |
$ | 8,665 | $ | 26,381 | $ | 60,470 | $ | 75,425 | ||||||||
Income tax expense |
5,574 | 19,330 | 39,989 | 56,809 | ||||||||||||
Other income |
(148 | ) | | (464 | ) | | ||||||||||
Loss on early retirement of debt |
| | | 31,018 | ||||||||||||
Interest expense, net of interest income |
27,677 | 24,015 | 86,998 | 74,808 | ||||||||||||
Equity in (earnings) losses of unconsolidated subsidiaries |
186 | (1,653 | ) | 186 | (1,329 | ) | ||||||||||
Stock compensation expense: |
||||||||||||||||
Included in general and administrative |
20 | 488 | 311 | 1,436 | ||||||||||||
Included in cost of services |
440 | 430 | 1,094 | 1,262 | ||||||||||||
Depreciation and amortization |
17,012 | 17,545 | 51,333 | 52,766 | ||||||||||||
Adjusted EBITDA |
$ | 59,426 | $ | 86,536 | $ | 239,917 | $ | 292,195 | ||||||||
Specialty hospitals |
$ | 58,282 | $ | 81,570 | $ | 214,523 | $ | 273,004 | ||||||||
Outpatient rehabilitation |
20,339 | 19,435 | 66,813 | 65,308 | ||||||||||||
Other (1) |
(19,195 | ) | (14,469 | ) | (41,419 | ) | (46,117 | ) | ||||||||
Adjusted EBITDA |
$ | 59,426 | $ | 86,536 | $ | 239,917 | $ | 292,195 | ||||||||
(1) | Other primarily includes general and administrative costs. |
VIII. Reconciliation of Net Income Per Share to Adjusted Net Income Per Share
For the Nine Months Ended September 30, 2010 and 2011
(In thousands, except per share amounts, unaudited)
For the Nine Months Ended September 30, 2010 and 2011
(In thousands, except per share amounts, unaudited)
Per Share | Per Share | |||||||||||||||
2010 | (a) | 2011 | (a) | |||||||||||||
Net income attributable to Select Medical Holdings Corporation |
56,697 | 0.35 | 70,987 | 0.47 | ||||||||||||
Earnings allocated to unvested restricted stockholders |
(135 | ) | (0.00 | ) | (763 | ) | (0.01 | ) | ||||||||
Net income available to common stockholders |
56,562 | 0.35 | 70,224 | 0.46 | ||||||||||||
Adjustment for early retirement of debt: |
||||||||||||||||
Loss on early retirement of debt |
| | 31,018 | 0.20 | ||||||||||||
Estimated income tax benefit (b) |
| | (11,796 | ) | (0.07 | ) | ||||||||||
Earnings allocated to unvested restricted stockholders |
| | (207 | ) | (0.00 | ) | ||||||||||
Adjusted net income available to common stockholders |
$ | 56,562 | $ | 0.35 | $ | 89,239 | $ | 0.59 | ||||||||
Adjustment for dilution |
0.00 | 0.00 | ||||||||||||||
Adjusted net income available to common stockholders diluted shares |
$ | 0.35 | $ | 0.59 | ||||||||||||
Weighted average common shares outstanding: |
||||||||||||||||
Basic |
159,698 | 152,299 | ||||||||||||||
Diluted |
159,964 | 152,522 |
(a) | Per share amounts for each period presented are basic weighted average common shares outstanding for all amounts except adjusted net income available to common
stockholders diluted shares, which is based on diluted shares outstanding. |
|
(b) | Represents the estimated tax benefit on the adjustments to net income. |